Peter Beitsch

Genomicists & clinicians are beginning to offer patients #genomictesting for a list of treatable diseases apart from the one that brought them into the clinic. Learn about the role secondary findings play in diagnosing #diseases & saving lives: ow.ly/OzOg50EO02i

At Medneon, our #mission is to empower individuals and their care team to get ahead of life-threatening disease. Learn how this little pup named Polly represents Medneon’s big mission, from our very own Kelly Bontempo: blog.medneon.com/meet-polly/ #RiskAssessment #GeneticInsights

At Medneon, we’re on a mission to prevent cancer, and we believe that information and insights have the power to do so. That’s why today, we’re delighted to launch the Medneon #blog, a place for #doctors, #genetics experts, #data scientists, and #technologists to explore…

Direct-to-consumer #genetictests use SNP genotyping to identify common variants in the general population — but exactly how accurate are they in identifying rare mutations?  Results from a recent study published in #theBMJ suggest SNP chips are “the wrong tool for the job.”

...with solid tumors were positive for pathogenic or likely pathogenic variants in dominant & recessive cancer predisposition #genes when including all levels of penetrance. The author recommends germline testing be considered for ALL children with cancer: clinicalomics.com/topics/onc…

“Think of it this way: When your doctor orders genetic testing, it’s akin to fishing for a particular fish, in a part of the ocean where it’s known to live. A DTC test is more like throwing a net into the ocean and seeing what comes back.” More here: consumerreports.org/genetic-…

A new @ConsumerReports article details the limitations - and possible dangers - of direct-to-consumer #genetictesting. When it comes to assessing #geneticrisk, experts advise relying on #healthcare providers and #geneticcounselors.

Big news: Medneon’s tools are being added to @Invitae's education and clinical support offerings. These additions will make it easier for #clinicians to use #genetics to improve #patientcare. Learn more: ow.ly/YDNc50DJOIs #riskassessment #precisionhealth

Recommendations for germline #genetictesting of pediatric patients with #cancer is typically tumor specific, and in some cases, driven by #familyhistory. Results from a recent study of pediatric patients, however, suggest this evolves. Researchers found that 18% of patients…

Informed providers result in empowered patients. The unique service provided by #GeneticCounselors is increasingly important in the era of #PersonalizedMedicine. This article highlights the need for increased #GeneticEducation for non-genetic providers: ow.ly/IT4150Dv3Ce

Although risk of developing #breastcancer is lower for women without family history, a new study found that 30% of breast #cancermutations occurred in women who are not considered high-risk. We must rethink our approach to #riskmanagement. More here: medscape.com/viewarticle/944…

A recent #oncology study found a striking 29.6% increase in adolescent & young adult #cancer incidence b/w 1973 & 2015. Environmental factors, dietary & obesity trends, & changes in screening practices may have played the biggest role. So, what can we do to change course?